Risk factors associated with prolonged intestinal colonization of ESBL-producing Enterobacteriaceae – a prospective cohort study

References

• World Health Organization. Antimicrobial resistance: global report on surveillance [Internet]. 2014 Available from: https://www.who.int/drugresistance/documents/surveillancereport/en/. Accessed 807, 2019.
   Google Scholar
• European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe [Internet]. 2016 Available from: https://ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2016. Accessed 807, 2019.
   Google Scholar
• Holmes AH, Moore LS, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387(10014):176–187. doi:10.1016/S0140-6736(15)00473-026603922
   PubMed Web of Science ®Google Scholar
• Jorgensen SB, Soraas AV, Arnesen LS, Leegaard TM, Sundsfjord A, Jenum PA. A comparison of extended spectrum beta-lactamase producing Escherichia coli from clinical, recreational water and wastewater samples associated in time and location. PLoS One. 2017;12(10):e0186576. doi:10.1371/journal.pone.018657629040337
   PubMed Web of Science ®Google Scholar
• Nowrouzian FL, Adlerberth I, Wold AE. Enhanced persistence in the colonic microbiota of Escherichia coli strains belonging to phylogenetic group B2: role of virulence factors and adherence to colonic cells. Microbes Infect. 2006;8(3):834–840. doi:10.1016/j.micinf.2005.10.01116483819
   PubMed Web of Science ®Google Scholar
• Nowrouzian FL, Wold AE, Adlerberth I. Escherichia coli strains belonging to phylogenetic group B2 have superior capacity to persist in the intestinal microflora of infants. J Infect Dis. 2005;191(7):1078–1083. doi:10.1086/42799615747243
   PubMed Web of Science ®Google Scholar
• Johnson JR, Delavari P, Kuskowski M, Stell AL. Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli. J Infect Dis. 2001;183(1):78–88. doi:10.1086/31765611106538
   PubMed Web of Science ®Google Scholar
• van Duijkeren E, Wielders CCH, Dierikx CM, et al. Long-term carriage of extended-spectrum beta-lactamase-producing Escherichia coli and klebsiella pneumoniae in the general population in The Netherlands. Clin Infect Dis. 2018;66(9):1368–1376. doi:10.1093/cid/cix101529149242
   PubMed Web of Science ®Google Scholar
• Titelman E, Hasan CM, Iversen A, et al. Faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors. Clin Microbiol Infect. 2014;20(8):O508–O515. doi:10.1111/1469-0691.1274224450760
   PubMed Web of Science ®Google Scholar
• Jorgensen SB, Soraas A, Sundsfjord A, Liestol K, Leegaard TM, Jenum PA. Fecal carriage of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae after urinary tract infection – a three year prospective cohort study. PLoS One. 2017;12(3):e0173510. doi:10.1371/journal.pone.017351028267783
   PubMed Web of Science ®Google Scholar
• Overdevest I, Haverkate M, Veenemans J, et al. Prolonged colonisation with Escherichia coli O25: ST131 versus other extended-spectrum beta-lactamase-producing E. coli in a long-term care facility with high endemic level of rectal colonisation, the Netherlands, 2013 to 2014. Euro Surveill. 2016;21(42). doi:10.2807/1560-7917.ES.2016.21.42.30376
   Google Scholar
• Rodriguez-Revuelta MJ, Lopez-Cerero L, Serrano L, Luna-Lagares S, Pascual A, Rodriguez-Bano J. Duration of colonization by extended-spectrum beta-lactamase-producing Enterobacteriaceae in healthy newborns and associated risk factors: a prospective cohort study. Open Forum Infect Dis. 2018;5(12):ofy312. doi:10.1093/ofid/ofy31230568982
   PubMed Web of Science ®Google Scholar
• Lohr IH, Rettedal S, Natas OB, Naseer U, Oymar K, Sundsfjord A. Long-term faecal carriage in infants and intra-household transmission of CTX-M-15-producing Klebsiella pneumoniae following a nosocomial outbreak. J Antimicrob Chemother. 2013;68(5):1043–1048. doi:10.1093/jac/dks50223288401
   PubMed Web of Science ®Google Scholar
• Papst L, Beovic B, Seme K, Pirs M. Two-year prospective evaluation of colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae: time course and risk factors. Infect Dis (Lond). 2015;47(9):618–624. doi:10.3109/23744235.2015.103300325865350
   PubMed Web of Science ®Google Scholar
• Ruppe E, Armand-Lefevre L, Estellat C, et al. High rate of acquisition but short duration of carriage of multidrug-resistant enterobacteriaceae after travel to the tropics. Clin Infect Dis. 2015;61(4):593–600. doi:10.1093/cid/civ33325904368
   PubMed Web of Science ®Google Scholar
• Jallad MA, Naoufal R, Irani J, Azar E. Extended spectrum beta-lactamase carriage state among elderly nursing home residents in Beirut. ScientificWorldJournal. 2015;2015:987580.25866842
   PubMedGoogle Scholar
• Lubbert C, Straube L, Stein C, et al. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany. Int J Med Microbiol. 2015;305(1):148–156. doi:10.1016/j.ijmm.2014.12.00125547265
   PubMed Web of Science ®Google Scholar
• Birgand G, Armand-Lefevre L, Lolom I, Ruppe E, Andremont A, Lucet JC. Duration of colonization by extended-spectrum beta-lactamase-producing Enterobacteriaceae after hospital discharge. Am J Infect Control. 2013;41(5):443–447. doi:10.1016/j.ajic.2012.05.01522998785
   PubMed Web of Science ®Google Scholar
• Paltansing S, Vlot JA, Kraakman ME, et al. Extended-spectrum beta-lactamase-producing enterobacteriaceae among travelers from the Netherlands. Emerg Infect Dis. 2013;19(8):1206–1213. doi:10.3201/eid.1908.13025723885972
   PubMed Web of Science ®Google Scholar
• Li B, Zhong Y, Fu XC, et al. Duration of stool colonization in healthy medical students with extended-spectrum-beta-lactamase-producing Escherichia coli. Antimicrob Agents Chemother. 2012;56(8):4558–4559. doi:10.1128/AAC.00171-1222687506
   PubMed Web of Science ®Google Scholar
• Rogers BA, Kennedy KJ, Sidjabat HE, Jones M, Collignon P, Paterson DL. Prolonged carriage of resistant E. coli by returned travellers: clonality, risk factors and bacterial characteristics. Eur J Clin Microbiol Infect Dis. 2012;31(9):2413–2420. doi:10.1007/s10096-012-1584-z22391758
   PubMed Web of Science ®Google Scholar
• Zahar JR, Lanternier F, Mechai F, et al. Duration of colonisation by Enterobacteriaceae producing extended-spectrum beta-lactamase and risk factors for persistent faecal carriage. J Hosp Infect. 2010;75(1):76–78. doi:10.1016/j.jhin.2009.11.01020227136
   PubMed Web of Science ®Google Scholar
• Tangden T, Cars O, Melhus A, Lowdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother. 2010;54(9):3564–3568. doi:10.1128/AAC.00220-1020547788
   PubMed Web of Science ®Google Scholar
• Ruppe E, Andremont A, Armand-Lefevre L. Digestive tract colonization by multidrug-resistant Enterobacteriaceae in travellers: an update. Travel Med Infect Dis. 2018;21:28–35. doi:10.1016/j.tmaid.2017.11.00729155322
   PubMed Web of Science ®Google Scholar
• OstholmBalkhed A, Tarnberg M, Nilsson M, et al. Duration of travel-associated faecal colonisation with ESBL-producing Enterobacteriaceae – a one year follow-up study. PLoS One. 2018;13(10):e0205504. doi:10.1371/journal.pone.020550430356258
   PubMed Web of Science ®Google Scholar
• Morales Barroso I, Lopez-Cerero L, Navarro MD, Gutierrez-Gutierrez B, Pascual A, Rodriguez-Bano J. Intestinal colonization due to Escherichia coli ST131: risk factors and prevalence. Antimicrob Resist Infect Control. 2018;7:135. doi:10.1186/s13756-018-0427-930473785
   PubMed Web of Science ®Google Scholar
• Karanika S, Karantanos T, Arvanitis M, Grigoras C, Mylonakis E. Fecal colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae and risk factors among healthy individuals: a systematic review and metaanalysis. Clin Infect Dis. 2016;63(3):310–318. doi:10.1093/cid/ciw28327143671
   PubMed Web of Science ®Google Scholar
• Statistics Sweden. Population in the country, counties and municipalities on 31/ 12/16 and Population change in 2016 2016. Available from: https://www.scb.se/hitta-statistik/statistik-efter-amne/befolkning/befolkningens-sammansattning/befolkningsstatistik/pong/tabell-och-diagram/helarsstatistik–kommun-lan-och-riket/folkmangd-i-riket-lan-och-kommuner-31-december-och-befolkningsforandringar/. Accessed 807, 2019.
   Google Scholar
• Rodriguez-Bano J, Navarro MD, Romero L, et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol. 2004;42(3):1089–1094. doi:10.1128/jcm.42.3.1089-1094.200415004058
   PubMed Web of Science ®Google Scholar
• Bonkat G, Muller G, Braissant O, et al. Increasing prevalence of ciprofloxacin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates. World J Urol. 2013;31(6):1427–1432. doi:10.1007/s00345-013-1031-523358791
   PubMed Web of Science ®Google Scholar
• Tukenmez Tigen E, Tandogdu Z, Ergonul O, et al. Outcomes of fecal carriage of extended-spectrum beta-lactamase after transrectal ultrasound-guided biopsy of the prostate. Urology. 2014;84(5):1008–1015. doi:10.1016/j.urology.2014.04.06025239255
   PubMed Web of Science ®Google Scholar
• Williamson DA, Roberts SA, Paterson DL, et al. Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen. Clin Infect Dis. 2012;54(10):1406–1412. doi:10.1093/cid/cis19422419681
   PubMed Web of Science ®Google Scholar
• Isendahl J, Giske CG, Hammar U, et al. Temporal dynamics and risk factors for bloodstream infection with extended-spectrum beta-lactamase-producing bacteria in previously colonized individuals: national population-based cohort study.
   Google Scholar
• Arcilla MS, van Hattem JM, Haverkate MR, et al. Import and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study. Lancet Infect Dis. 2017;17(1):78–85. doi:10.1016/S1473-3099(16)30319-X27751772
   PubMed Web of Science ®Google Scholar
• Lindblom A, Karami N, Magnusson T, Ahren C. Subsequent infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae in patients with prior infection or fecal colonization. Eur J Clin Microbiol Infect Dis. 2018;37(8):1491–1497. doi:10.1007/s10096-018-3275-x29796984
   PubMed Web of Science ®Google Scholar
• Ny S, Lofmark S, Borjesson S, et al. Community carriage of ESBL-producing Escherichia coli is associated with strains of low pathogenicity: a Swedish nationwide study. J Antimicrob Chemother. 2017;72(2):582–588. doi:10.1093/jac/dkw41927798205
   PubMed Web of Science ®Google Scholar
• Banerjee R, Johnson JR. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother. 2014;58(9):4997–5004. doi:10.1128/AAC.02824-1424867985
   PubMed Web of Science ®Google Scholar
• Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis. 2010;51(3):286–294. doi:10.1086/65393220572763
   PubMed Web of Science ®Google Scholar
• Leo S, Lazarevic V, Gaia N, et al. The intestinal microbiota predisposes to traveler’s diarrhea and to the carriage of multidrug-resistant Enterobacteriaceae after traveling to tropical regions. Gut Microbes. 2019;1–11. doi:10.1080/19490976.2018.1564431
   Web of Science ®Google Scholar
• Alsterlund R, Axelsson C, Olsson-Liljequist B. Long-term carriage of extended-spectrum beta-lactamase-producing Escherichia coli. Scand J Infect Dis. 2012;44(1):51–54. doi:10.3109/00365548.2011.59298721736509
   PubMed Web of Science ®Google Scholar
• Sweden TPHAo. ESBL-producerande Tarmbakterier Kunskapsunderlag Med Förslag till Handläggning För Att Begränsa Spridningen Av Enterobacteriaceae Med ESBL; 2014 Available from: https://www.folkhalsomyndigheten.se/contentassets/f4df42e7e643414ba3499a9ee1801915/esbl-producerande-tarmbakterier.pdf
   Google Scholar